Glob Bioenergi Stock Current Asset
| ALGBE Stock | EUR 0.87 0.04 4.82% |
Glob Bioenergi fundamentals help investors to digest information that contributes to Glob Bioenergi's financial success or failures. It also enables traders to predict the movement of Glob Stock. The fundamental analysis module provides a way to measure Glob Bioenergi's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Glob Bioenergi stock.
Glob |
Glob Bioenergi Company Current Asset Analysis
Glob Bioenergi's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Glob Bioenergi Current Asset | 13 M |
Most of Glob Bioenergi's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Glob Bioenergi is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, Glob Bioenergi has a Current Asset of 13 M. This is 99.95% lower than that of the Chemicals sector and 99.66% lower than that of the Materials industry. The current asset for all France stocks is 99.86% higher than that of the company.
Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Glob Fundamentals
| Return On Equity | -1.13 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (7.69) % | |||
| Current Valuation | 51.76 M | |||
| Shares Outstanding | 14.85 M | |||
| Shares Owned By Insiders | 15.64 % | |||
| Shares Owned By Institutions | 10.01 % | |||
| Price To Earning | (5.10) X | |||
| Price To Book | 4.37 X | |||
| Price To Sales | 60.53 X | |||
| Revenue | 100.94 K | |||
| Gross Profit | (5.32 M) | |||
| EBITDA | (12.13 M) | |||
| Net Income | (11.77 M) | |||
| Cash And Equivalents | 146.65 K | |||
| Cash Per Share | 2.12 X | |||
| Total Debt | 5.13 M | |||
| Debt To Equity | 145.30 % | |||
| Current Ratio | 1.58 X | |||
| Book Value Per Share | 0.88 X | |||
| Cash Flow From Operations | (11.88 M) | |||
| Earnings Per Share | (0.48) X | |||
| Target Price | 9.7 | |||
| Number Of Employees | 48 | |||
| Beta | 1.93 | |||
| Market Capitalization | 41.6 M | |||
| Total Asset | 31.79 M | |||
| Retained Earnings | (28 M) | |||
| Working Capital | 11 M | |||
| Current Asset | 13 M | |||
| Current Liabilities | 2 M | |||
| Z Score | 4.8 | |||
| Net Asset | 31.79 M |
About Glob Bioenergi Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Glob Bioenergi's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Glob Bioenergi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Glob Bioenergi based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Glob Stock Analysis
When running Glob Bioenergi's price analysis, check to measure Glob Bioenergi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glob Bioenergi is operating at the current time. Most of Glob Bioenergi's value examination focuses on studying past and present price action to predict the probability of Glob Bioenergi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glob Bioenergi's price. Additionally, you may evaluate how the addition of Glob Bioenergi to your portfolios can decrease your overall portfolio volatility.